Yuhan accelerates global Leclaza growth as indications widen and reimbursement lags Rising global uptake hinges on faster ...
Northwestern Medicine scientists have identified a stem-like state in small-cell lung cancer that distinguishes a group of ...
A University of Toronto professor talks about his discoveries that could improve the treatment of the most aggressive tumors, ...
A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with ...
EU application is back under EMA review for EGFR-mutated NSCLC. Find out what this resubmission means for patients today.
Dosed first patient in registrational Phase 3 DAYBreak CLL-306 trial comparing bexobrutideg with pirtobrutinib in relapsed/refractory ...
There are around 125,000 lung cancer deaths in the U.S. every year and around 32,800 lung cancer deaths in the U.K. annually.
Posts Not To Miss From DCLung26 / cancer surgery, Cancer Treatment Advances, clinical oncology, DC Lung Cancer Conference ...
A Hong Kong model compared upfront NGS with EGFR/ALK-first testing in metastatic NSCLC, highlighting trade-offs in cost, ...
TAHLEQUAH, Okla. The American Lung Association’s statistics on lung cancer in Oklahoma reveals those surviving the disease ...
From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results